Although still used there is no evidence that they are any better than newer antidepressants
in treating depression
in parkinson's patients.
In fact they may actually be more risky since the older antidepressants have many more side effects. They interact with more receptor sites in the brain than newer antidepressants raising the chances of serious unwanted side effects.